A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine Injection) Used in China
NCT03189199 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2017-06-20
Summary
The purpose of this study is to make a cohort event monitoring to see whether and how Dazhuhongjingtian injection in hospital results in adverse events or adverse drug reactions
Conditions
Interventions
- OTHER
-
a cohort using Dazhuhongjingtian injection
All patients will be measured and assessed at the time Dazhuhongjingtian Injection is administered to them until they discharge. Patients using Dazhuhongjingtian Injection will be registered on a registration form including disease background, Dazhuhongjingtian Injection's administration, and extraction information from hospital information system. An adverse event or drug adverse reaction form also will be used to describe any doubted symptoms or signs from patients. A judgment will be made by doctors directly and a further analysis will be conducted by researchers to decide those potential side effects of Dazhuhongjingtian Injection.
Sponsors & Collaborators
-
Hospital of Changchun University of Traditional Chinese Medicine
collaborator UNKNOWN -
China Academy of Chinese Medical Sciences
lead OTHER
Principal Investigators
-
Yan Ming Xie, BA · Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Eligibility
- Min Age
- 1 Hour
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-19
- Primary Completion
- 2017-07-19
- Completion
- 2019-12-31
More Related Trials
-
A Registry Study of Shuxuening Injection Used in Hospitals in China
NCT01752946 ·Status: UNKNOWN
-
Safety Study of Kudiezi (a Chinese Medicine Injection) Used in Hospitals in China
NCT01612559 ·Status: UNKNOWN
-
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
NCT02239237 ·Status: COMPLETED
-
A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China
NCT03461692 ·Status: UNKNOWN
-
Safety Study of Shenfu (a Chinese Medicine Injection) Used in Hospitals in China
NCT01612533 ·Status: UNKNOWN
-
Traditional Chinese Medicine for Treatment of Chronic Heart Failure
NCT01939236 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
NCT05000411 ·Status: UNKNOWN ·Phase: PHASE4
-
Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study
NCT07088523 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
NCT00965471 ·Status: COMPLETED ·Phase: NA
-
Danhong Injection in the Treatment of Chronic Stable Angina
NCT01681316 ·Status: COMPLETED ·Phase: PHASE4
-
DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris
NCT03633890 ·Status: UNKNOWN ·Phase: PHASE4
-
TCM Differentiation and Treatment Protocol of COVID-19
NCT04306497 ·Status: COMPLETED
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Kudiezi(Yueanxin,a Chinese Medicine Injection)Used in Hospitals in China
NCT01781676 ·Status: UNKNOWN
-
Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
NCT01764204 ·Status: COMPLETED
-
Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality
NCT03018769 ·Status: UNKNOWN
-
Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment
NCT07041359 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects
NCT04164290 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
NCT04022031 ·Status: UNKNOWN
-
Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat
NCT01612260 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Antiaging Effect of Chinese Herb Drink
NCT02634242 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection
NCT06636422 ·Status: NOT_YET_RECRUITING
-
Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure
NCT03027375 ·Status: UNKNOWN ·Phase: PHASE2
-
Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen
NCT01033630 ·Status: COMPLETED ·Phase: PHASE2
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)
NCT06220019 ·Status: NOT_YET_RECRUITING